{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:31:21Z","timestamp":1793910681938,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore activity and mechanism of naringin in the treatment of PIC (Post-Infectious Cough) by virtue of network pharmacology and animal studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The targets associated with naringin were obtained from the SwissTargetPrediction and Super-PRED databases. Disease-related targets were collected from GeneCards and OMIM (Online Mendelian Inheritance in Man). Venny was utilized to identify the overlapping targets between naringin and the disease. PPI (Protein\u2013Protein Interaction) networks for disease-related targets were constructed using STRING and Cytoscape 3.10.1. GO (Gene Ontology) functional annotation and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analyses were performed with Metascape. Molecular docking between key targets and naringin was conducted using AutoDock Vina. In the animal experiments, PIC models were established in guinea pigs via intranasal inoculation with A\/PR\/8 virus, and cough frequency was measured after citric acid-induced coughing. Morphological changes in lung tissue and airways were assessed using the HE (Hematoxylin\u2013Eosin) staining method. The relative expression levels of IL-8 (Interleukin-8), IL-1\u03b2 (Interleukin-1\u03b2), TNF-\u03b1 (Tumor Necrosis Factor-Alpha), and NF-\u03baB p65 (Nuclear Factor Kappa-B p65 Subunit) mRNA were analyzed by RT-qPCR (Reverse Transcription Quantitative Polymerase Chain Reaction). SOD (Superoxide Dismutase) activity in lung tissue was measured using a colorimetric assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After screening, naringin may contribute to the treatment of post-infectious cough by targeting proteins expressed by core genes such as HSP90AA1 (HSP 90-Alpha), TLR4 (Toll-like Receptor 4), MTOR (Mechanistic Target of Rapamycin), HIF1A (Hypoxia-Inducible Factor Alpha), and NF-\u03baB1 (Nuclear Factor Kappa-B Subunit 1). KEGG enrichment analysis revealed involvement in pathways including the HIF-1 (Hypoxia-Inducible Factor 1) signaling pathway and the PD-L1 (Programmed Death-Ligand 1) expression and PD-1 (Programmed Cell Death Protein 1) checkpoint pathway in cancer. Molecular docking results indicated that naringin exhibited strong binding affinity with HSP90AA1, TLR4, MTOR, HIF1A, NF-\u03baB1, NOS3 (Nitric Oxide Synthase 3), and GRB2 (Growth Factor Receptor-Bound Protein 2). In animal experiments, compared to the normal group, guinea pigs in the model group exhibited a significantly higher number of coughs, pronounced lung tissue hyperplasia, and inflammatory cell infiltration. Additionally, the relative expression of IL-8, IL-1\u03b2, TNF-\u03b1, and NF-\u03baB p65 mRNA was significantly increased, while lung tissue SOD activity was decreased. Treatment with naringin significantly reduced the number of coughs, attenuated pathological changes in lung tissue, lowered the lung index, decreased the relative expression of IL-8, IL-1\u03b2, TNF-\u03b1, and NF-\u03baB p65 mRNA, and significantly increased SOD activity in lung tissue compared to the model group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Naringin shows therapeutic potential to alleviate PIC symptoms in a guinea pig model through anti-inflammatory and antioxidant mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-025-03788-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:48:45Z","timestamp":1752137325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Activity and mechanism of naringin in the treatment of post-infectious cough"],"prefix":"10.1186","volume":"25","author":[{"given":"Yinghan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenda","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"2","key":"3788_CR1","first-page":"213","volume":"45","author":"FY Li","year":"2022","unstructured":"Li FY, Deng Z. Progress in the pathogenesis of post-infectious persistent cough. Zhonghua Jie He He Hu Xi Za Zhi. 2022;45(2):213\u20137.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"1","key":"3788_CR2","first-page":"13","volume":"45","author":"Asthma Group of Chinese Thoracic Society","year":"2022","unstructured":"Asthma Group of Chinese Thoracic Society. Chinese national guide line on diagnosis and management of cough (2021). Chin J Tuberc Respir Dis. 2022;45(1):13\u201346.","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"4","key":"3788_CR3","first-page":"494","volume":"14","author":"W Jiang","year":"2022","unstructured":"Jiang W, Qi J, Li X, Chen G, Zhou D, Xiao W, et al. Post-infectious cough of different syndromes treated by traditional Chinese medicines: a review. Chin Herb Med. 2022;14(4):494\u2013510.","journal-title":"Chin Herb Med"},{"issue":"7","key":"3788_CR4","first-page":"11","volume":"56","author":"J Lu","year":"2022","unstructured":"Lu J, Shi WH, Zhang P, et al. Application of insect traditional Chinese medicine in cough after infection based on collateral disease theory. Shanghai J Tradit Chin Med. 2022;56(7):11\u20133, 37.","journal-title":"Shanghai J Tradit Chin Med"},{"issue":"4","key":"3788_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3945\/an.113.005603","volume":"5","author":"MA Alam","year":"2014","unstructured":"Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 2014;5(4):404\u201317.","journal-title":"Adv Nutr"},{"issue":"D1","key":"3788_CR6","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49(D1):D1388\u201395.","journal-title":"Nucleic Acids Res"},{"key":"3788_CR7","doi-asserted-by":"crossref","unstructured":"Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014;42(Web Server issue):W32\u20138.","DOI":"10.1093\/nar\/gku293"},{"key":"3788_CR8","doi-asserted-by":"crossref","unstructured":"Nickel J, Gohlke BO, Erehman J, Banerjee P, Rong WW, Goede A, et al. SuperPred: update on drug classification and target prediction. Nucleic Acids Res. 2014;42(Web Server issue):W26-W31.","DOI":"10.1093\/nar\/gku477"},{"key":"3788_CR9","doi-asserted-by":"crossref","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1\u20131.30.33.","DOI":"10.1002\/cpbi.5"},{"issue":"11","key":"3788_CR10","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1002\/ajmg.a.62407","volume":"185","author":"A Hamosh","year":"2021","unstructured":"Hamosh A, Amberger JS, Bocchini C, Scott AF, Rasmussen SA. Online Mendelian Inheritance in Man (OMIM\u00ae): Victor McKusick\u2019s magnum opus. Am J Med Genet A. 2021;185(11):3259\u201365.","journal-title":"Am J Med Genet A"},{"issue":"D1","key":"3788_CR11","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt Consortium","year":"2023","unstructured":"UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3788_CR12","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49(D1):D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3788_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"1","key":"3788_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/s-0030-1250117","volume":"77","author":"S Gao","year":"2011","unstructured":"Gao S, Li P, Yang H, Fang S, Su W. Antitussive effect of naringin on experimentally induced cough in Guinea pigs. Planta Med. 2011;77(1):16\u201321.","journal-title":"Planta Med"},{"issue":"3","key":"3788_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.intimp.2012.04.019","volume":"13","author":"YL Luo","year":"2012","unstructured":"Luo YL, Zhang CC, Li PB, Nie YC, Wu H, Shen JG, et al. Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke. Int Immunopharmacol. 2012;13(3):301\u20137.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3788_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pupt.2008.12.022","volume":"22","author":"J Footitt","year":"2009","unstructured":"Footitt J, Johnston SL. Cough and viruses in airways disease: mechanisms. Pulm Pharmacol Ther. 2009;22(2):108\u201313.","journal-title":"Pulm Pharmacol Ther"},{"issue":"2","key":"3788_CR17","first-page":"239","volume":"19","author":"JM Chen","year":"2014","unstructured":"Chen JM, Li YL, Huang P, et al. Role of CD8+CD28-regulatory T cells in the pathogenesis of long-term cough after upper respiratory tract infection. J Clin Pulm Med. 2014;19(2):239\u201342.","journal-title":"J Clin Pulm Med"},{"issue":"5","key":"3788_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/ard.2005.042085","volume":"65","author":"C Duftner","year":"2006","unstructured":"Duftner C, Dejaco C, Kullich W, Klauser A, Goldberger C, Falkenbach A, et al. Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis. Ann Rheum Dis. 2006;65(5):647\u201353.","journal-title":"Ann Rheum Dis"},{"key":"3788_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jnutbio.2018.05.012","volume":"59","author":"JK Kim","year":"2018","unstructured":"Kim JK, Park JH, Ku HJ, Kim SH, Lim YJ, Park JW, et al. Naringin protects acrolein-induced pulmonary injuries through modulating apoptotic signaling and inflammation signaling pathways in mice. J Nutr Biochem. 2018;59:10\u20136.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"3788_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10753-016-0321-7","volume":"39","author":"X Guihua","year":"2016","unstructured":"Guihua X, Shuyin L, Jinliang G, Wang S. Naringin protects ovalbumin-induced airway inflammation in a mouse model of asthma. Inflammation. 2016;39(2):891\u20139.","journal-title":"Inflammation"},{"issue":"2","key":"3788_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s10753-014-9994-y","volume":"38","author":"SF Ahmad","year":"2015","unstructured":"Ahmad SF, Attia SM, Bakheet SA, Zoheir KM, Ansari MA, Korashy HM, et al. Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-kappab, STAT3 and pro-inflammatory mediators and enhancement of IkappaBalpha and anti-inflammatory cytokines. Inflammation. 2015;38(2):846\u201357.","journal-title":"Inflammation"},{"issue":"1","key":"3788_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.etap.2014.04.030","volume":"38","author":"Y Chen","year":"2014","unstructured":"Chen Y, Wu H, Nie YC, Li PB, Shen JG, Su WW. Mucoactive effects of naringin in lipopolysaccharide-induced acute lung injury mice and beagle dogs. Environ Toxicol Pharmacol. 2014;38(1):279\u201387.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"10","key":"3788_CR23","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.intimp.2011.05.022","volume":"11","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wu H, Nie YC, Chen JL, Su WW, Li PB. Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappaB pathway. Int Immunopharmacol. 2011;11(10):1606\u201312.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3788_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12903-022-02304-0","volume":"22","author":"H Zhang","year":"2022","unstructured":"Zhang H, Huang J, Fan X, Miao R, Wang Y. HSP90AA1 promotes the inflammation in human gingival fibroblasts induced by Porphyromonas gingivalis lipopolysaccharide via regulating of autophagy. BMC Oral Health. 2022;22(1):366.","journal-title":"BMC Oral Health"},{"key":"3788_CR25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3389\/fimmu.2020.01455","volume":"11","author":"P Zhang","year":"2020","unstructured":"Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-Like Receptor 4 (TLR4)\/Opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility. Front Immunol. 2020;11:1455.","journal-title":"Front Immunol"},{"key":"3788_CR26","doi-asserted-by":"publisher","first-page":"8874339","DOI":"10.1155\/2021\/8874339","volume":"2021","author":"MM Aboudounya","year":"2021","unstructured":"Aboudounya MM, Heads RJ. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm. 2021;2021:8874339.","journal-title":"Mediators Inflamm"},{"key":"3788_CR27","doi-asserted-by":"publisher","first-page":"155850","DOI":"10.1016\/j.phymed.2024.155850","volume":"132","author":"Z Yang","year":"2024","unstructured":"Yang Z, Li X, Wei L, Bao L, Hu H, Liu L, et al. Involucrasin B suppresses airway inflammation in obese asthma by inhibiting the TLR4-NF-kappaB-NLRP3 pathway. Phytomedicine. 2024;132:155850.","journal-title":"Phytomedicine"},{"issue":"1","key":"3788_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s11658-024-00631-4","volume":"29","author":"X Deng","year":"2024","unstructured":"Deng X, Li Y, Chen Y, Hu Q, Zhang W, Chen L, et al. Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK\/mTOR signaling pathway. Cell Mol Biol Lett. 2024;29(1):119.","journal-title":"Cell Mol Biol Lett"},{"key":"3788_CR29","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"key":"3788_CR30","doi-asserted-by":"crossref","unstructured":"Zhou QL, Wang TY, Li M, Shang YX. Alleviating airway inflammation by inhibiting ERK-NF-kappaB signaling pathway by blocking Kv1.3 channels. Int Immunopharmacol. 2018;63:110\u20138.","DOI":"10.1016\/j.intimp.2018.07.009"},{"key":"3788_CR31","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/srep01142","volume":"3","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Jeong JS, Kim SR, Park SY, Chae HJ, Lee YC. Inhibition of endoplasmic reticulum stress alleviates lipopolysaccharide-induced lung inflammation through modulation of NF-kappaB\/HIF-1alpha signaling pathway. Sci Rep. 2013;3:1142.","journal-title":"Sci Rep"},{"issue":"1","key":"3788_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11940-024-00816-4","volume":"27","author":"A Soroush","year":"2025","unstructured":"Soroush A, Dunn JF. A hypoxia-inflammation cycle and multiple sclerosis: mechanisms and therapeutic implications. Curr Treat Options Neurol. 2025;27(1):6.","journal-title":"Curr Treat Options Neurol"},{"key":"3788_CR33","first-page":"105","volume":"345","author":"HZ Imtiyaz","year":"2010","unstructured":"Imtiyaz HZ, Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol. 2010;345:105\u201320.","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03788-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T02:44:25Z","timestamp":1757213065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03788-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3788"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03788-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6235576\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental\u00a0procedures\u00a0involving\u00a0animals\u00a0were\u00a0carried\u00a0out\u00a0in accordance\u00a0with\u00a0the\u00a0protocols\u00a0approved\u00a0by\u00a0the\u00a0Animal\u00a0Experiment\u00a0Com-mittee\u00a0(W230020)\u00a0of\u00a0the\u00a0Experimental\u00a0Animal\u00a0Center,\u00a0Zhongshan\u00a0Devel-opment\u00a0Zone\u00a0Laboratory,\u00a0China\u00a0National\u00a0Analytical\u00a0Center\u00a0in\u00a0Guangzho-u.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}